Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
To compare the effects of irinotecan hydrochloride with cisplatin to the "standard" regimen
etoposide plus cisplatin on overall survival, in chemotherapy-naive patients with newly
diagnosed Extensive Disease-Small Cell Lung Cancer (ED-SCLC).